Skip to main content
Julia Bridge, MD, Pathology, Omaha, NE

JuliaABridgeMD

Pathology Omaha, NE

Anatomic Pathology, Clinical Pathology

Professor/ University of Nebraska Medical Center Director Cytogenetics/Molecular Cytogenetics/ ProPath

Dr. Bridge is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Bridge's full profile

Already have an account?

Education & Training

  • University of Kansas School of Medicine
    University of Kansas School of MedicineResidency, Pathology-Anatomic and Clinical, 1984 - 1988
  • University of Nebraska College of Medicine
    University of Nebraska College of MedicineClass of 1984

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2018 - 2025
  • TX State Medical License
    TX State Medical License 2021 - 2025
  • AZ State Medical License
    AZ State Medical License 2018 - 2024
  • NE State Medical License
    NE State Medical License 1991 - 2024
  • American Board of Medical Genetics and Genomics Clinical Cytogenetics
  • American Board of Pathology Anatomic Pathology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Aneurysmal Bone Cyst of the Maxillary Sinus with USP6 Rearrangement: Case Report of a Rare Entity and Review of the Literature  
    Phillip D McMullen, Elizabeth A Blair, Carina W Yang, John Collins, Nicole A Cipriani, Julia A Bridge, Head and Neck Pathology

Authored Content

  • Proficiency Testing of Standardized Samples Shows High Interlaboratory Agreement for Clinical Next Generation Sequencing–Based Hematologic Malignancy Assays with Survey Material–Specific Differences in Variant FrequenciesJanuary 2020
  • Proficiency Testing of Standardized Samples Shows High Interlaboratory Agreement for Clinical Next Generation Sequencing–Based Hematologic Malignancy Assays with Survey Material–Specific Differences in Variant FrequenciesJanuary 2020

Press Mentions

  • Abstract 5269: Myxofibrosarcoma: A Move Toward Precision Medicine
    Abstract 5269: Myxofibrosarcoma: A Move Toward Precision MedicineAugust 1st, 2015

Grant Support

  • Core--Tissue ProcurementNational Cancer Institute2000–2008